Exicure Rg
Exicure, Inc. is a clinical‑stage biotech developing spherical nucleic acid (SNA) therapeutics for oncology, neurology, and inflammatory diseases. Its pipeline includes Phase‑1 trials for solid tumors and preclinical candidates for Friedreich’s ataxia.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 7
- HQ: Redwood City
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.